Understanding AI's Expanding Role in Drug Dis...

The contact center is shifting from a service channel to a primary point of fraud, where text‑based systems fail to catch the signals that surface only in live voice. In this episode, Mike Pappas, CEO & Co‑Founder at Modulate, joins Emerj's Nick Gertsch to examine how audio‑nativ ...  Show more

A growing number of enterprises are discovering that early agent wins don't translate into scale because agents can connect but cannot yet share context or improve as a coordinated system. In this episode, Papi Menon, Vice President of Product Management and Chief Product Officer ...  Show more

Bringing new drugs to market is a costly, time-consuming endeavor. On top of that, most medicines fail at some point in the research and development phase. Sarah Guo is joined by Sajith Wickramasekara, co-founder and CEO of Benchling, a company that has not only become the centra ...  Show more

Can AI compress the years long research time of a PhD into seconds? Research scientist Max Jaderberg explores how “AI analogs” simulate real-world lab work with staggering speed and scale, unlocking new insights on protein folding and drug discovery. Drawing on his experience wor ...  Show more

Max Jaderberg and Sergei Yakneen from Isomorphic Labs discuss how AI is enhancing drug discovery by treating biology as an information processing system. They share how advanced AI models like AlphaFold 3 are accelerating the pipeline and paving the way for a future of precision ...  Show more

Techbio is a field combining data, technology and biology to enhance scientific processes — and AI has the potential to supercharge the biopharmaceutical industry further. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Chris Gibson, cofounder and CEO of Rec ...  Show more